期刊文献+

HBV感染不同状态者血清Tim-3的差异及与HBeAg和HBV DNA的关系 被引量:1

Differences of serum Tim-3 in patients with different hepatitis B virus infections and its relationship with HBeAg and HBV DNA
下载PDF
导出
摘要 目的:探讨不同状态HBV感染者血清T细胞免疫球蛋白黏蛋白分子-3(Tim-3)差异,并分析其与HBeAg和HBV DNA的关系。方法:选取2017年6月至2019年6月于本院收治的50例HBV携带者(携带组)、60例慢性乙型肝炎患者(CHB组)、40例慢性乙型肝炎急性发作患者(急性发作组)和30例肝硬化患者(肝硬化组)作为研究对象,同期选取50例健康体检者作为对照组,同时检测各组对象ALT、HBeAg、HBV DNA、Tim-3水平,并做相关统计学分析。结果:携带组、CHB组、急性发作组、肝硬化组和对照组人员血清Tim-3水平分别为(13.79±3.52)、(15.04±4.38)、(21.32±5.44)、(1.11±5.83)和(10.57±2.45)pg/ml,5组比较差异有统计学意义(F=17.325,P=0.000);携带组、CHB组、急性发作组、肝硬化组患者和对照组人员血清ALT水平分别为(25.81±4.32)、(89.93±10.73)、(532.44±51.28)、(715.32±77.89)和(21.38±3.21)U/L,5组比较差异有统计学意义(F=45.271,P=0.000)。HBeAg阳性者和HBeAg阴性者血清Tim-3水平分别为(20.73±5.43)、(16.84±3.22)pg/ml,两者比较差异有统计学意义(t=5.297,P=0.000)。HBV DNA阳性者和HBV DNA阴性者血清Tim-3水平分别为(21.67±6.21)、(14.31±3.05)pg/ml,两者比较差异有统计学意义(t=10.356,P=0.000)。绘制ROC曲线发现,血清Tim-3在诊断HBV感染上具有一定价值(P<0.05),其曲线下面积为0.789,95%CI为0.711~0.842,截断值为16.45 pg/ml,敏感度为83.5%,特异度为80.1%。经Logistic回归分析发现,血清Tim-3是导致HBV进展的独立危险因素(P<0.05),OR值为1.83(95%CI:1.24~2.32)。结论:Tim-3在HBV感染不同状态者之间差异明显,且与HBeAg和HBV DNA状态相关,是导致HBV进展的独立危险因素。 Objective:To investigate the differences of serum T cell immunoglobulin mucin molecule-3(Tim-3)in patients with hepatitis B virus infection in different states,and to analyze its relationship with HBeAg and HBV DNA.Methods:From June 2017 to June 2019,50 patients with hepatitis B virus(carrying group),60 patients with chronic hepatitis B virus(CHB group),and 40 chronic hepatitis B writers(acute attack group)were selected.And 30 cases of chronic hepatitis B combined with liver cirrhosis group(cirrhosis group)as the research object,50 healthy subjects were selected as the control group at the same time;Tim-3,ALT,HBeAg and HBV DNA levels of each group were measured and collected for statistics Science analysis.Results:The serum Tim-3 levels in the carrier group,CHB group,acute attack group,cirrhosis group and control group were(13.79±3.52,15.04±4.38,21.32±5.44,17.11±5.83,and 10.57±2.45)pg/mL,five There were statistically significant differences between the two groups(F=17.325,P=0.000);the serum ALT levels in the carrier group,CHB group,acute attack group,cirrhosis group and control group were(25.81±4.32,89.93±10.73,532.44±51.28,715.32±77.89 and 21.38±3.21)U/L,the difference between the five groups was statistically significant(F=45.271,P=0.000).Serum Tim-3 levels in HBeAg-positive and HBeAg-negative patients were(20.73±5.43,16.84±3.22)pg/mL,respectively,and the difference was statistically significant(t=5.297,P=0.000).Serum Tim-3 levels were(21.67±6.21,14.31±3.05)pg/mL in HBV DNA positive and HBV DNA negative patients,respectively,and the difference was statistically significant(t=10.356,P=0.000).The ROC curve was drawn and found that serum Tim-3 has a certain value in the diagnosis of HBV infection(P<0.05).The area under the curve is 0.789,the 95%CI is 0.711~0.842,the cutoff value is 16.45 pg/mL,and the sensitivity is 83.5%,Specificity is 80.1%.Logistic regression analysis found that serum Tim-3 was an independent risk factor for HBV progression(P<0.05),and the OR value was 1.83(95%CI:1.24~2.32).Conclusion:Tim-3 has significant differences in different states of HBV infection,and is related to the status of HBeAg and HBV DNA,and is an independent risk factor for HBV progression.
作者 谭倩 段雨函 李锦貌 TAN Qian;DUAN Yu-han;LI Jin-mao(Clinical Laboratory Center,The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture,Enshi,Hubei,445000,China)
出处 《中西医结合肝病杂志》 CAS 2021年第11期1008-1011,共4页 Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
关键词 乙型肝炎病毒 T细胞免疫球蛋白黏蛋白分子-3 谷丙转氨酶 乙型肝炎病毒脱氧核糖核酸 hepatitis B virus infection T cell immunoglobulin mucin molecule-3 alanine aminotransferase hepatitis B virus DNA
  • 相关文献

参考文献8

二级参考文献127

  • 1庄辉.我国乙型肝炎病毒感染与挑战[J].中华传染病杂志,2005,23(S1):2-6. 被引量:120
  • 2马名驹,陈曦,阮玉华,陈其鹃,边会珍,梁姝,张莉,尹潞,王君,陈康林,卫大英,秦光明,张灵麟,汪宁,邵一鸣.共用注射器静脉吸毒与HIV感染关系的研究[J].预防医学情报杂志,2005,21(6):647-650. 被引量:13
  • 3刘崇柏,苏崇鳌,汪诚信.农村乙型肝炎防治健康教育效果分析[J].中国计划免疫,2006,12(2):91-93. 被引量:19
  • 4Chen CJ, Yang HI. Natural history of chronic hepatitis BREVEALed. J Gastroenterol Hepatol 2011; 26: 628-638 [PMID:21323729 DOI: 10.1111/j.1440-1746.2011.06695.x].
  • 5Fattovich G, Olivari N, Pasino M, D'Onofrio M, Martone E,Donato F. Long-term outcome of chronic hepatitis B in Caucasianpatients: mortality after 25 years. Gut 2008; 57: 84-90 [PMID:17715267 DOI: 10.1136/gut.2007.128496].
  • 6Sung WK, Zheng H, Li S, Chen R, Liu X, Li Y, Lee NP, LeeWH, Ariyaratne PN, Tennakoon C, Mulawadi FH, Wong KF, LiuAM, Poon RT, Fan ST, Chan KL, Gong Z, Hu Y, Lin Z, WangG, Zhang Q, Barber TD, Chou WC, Aggarwal A, Hao K, ZhouW, Zhang C, Hardwick J, Buser C, Xu J, Kan Z, Dai H, Mao M,Reinhard C, Wang J, Luk JM. Genome-wide survey of recurrentHBV integration in hepatocellular carcinoma. Nat Genet 2012; 44:765-769 [PMID: 22634754 DOI: 10.1038/ng.2295].
  • 7Summers J, Mason WS. Replication of the genome of a hepatitisB--like virus by reverse transcription of an RNA intermediate. Cell1982; 29: 403-415 [PMID: 6180831 DOI: 10.1016/0092-8674(82)90157-X].
  • 8Seeger C, Mason WS. Hepatitis B virus biology. MicrobiolMol Biol Rev 2000; 64: 51-68 [PMID: 10704474 DOI: 10.1128/MMBR.64.1.51-68.2000].
  • 9Loggi E, Gamal N, Bihl F, Bernardi M, Andreone P. Adaptiveresponse in hepatitis B virus infection. J Viral Hepat 2014; 21:305-313 [PMID: 24674098 DOI: 10.1111/jvh.12255].
  • 10Busca A, Kumar A. Innate immune responses in hepatitis B virus(HBV) infection. Virol J 2014; 11: 22 [PMID: 24507433 DOI:10.1186/1743-422X-11-22].

共引文献796

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部